Severe reperfusion lung injury after double lung transplantation
- PMID: 12133185
- PMCID: PMC125313
- DOI: 10.1186/cc1496
Severe reperfusion lung injury after double lung transplantation
Abstract
Aim: To demonstrate the effects of combined inhaled nitric oxide and surfactant replacement as treatment for acute respiratory distress syndrome. This treatment has not previously been documented for reperfusion injury after double lung transplantation.
Method: A 24-year-old female with cystic fibrosis underwent double lung transplantation. During implantation of the second lung a marked increase in pulmonary artery pressure associated with systemic hypotension, hypoxemia and low cardiac output were observed. Notwithstanding the patient received support from cardiovascular drugs and pulmonary vasodilators cardiopulmonary by-pass was necessary. In the intensive care unit the patient received the same drug support, inhaled nitric oxide and two bronchoscopic applications of bovine surfactant.
Results: A rapid improvement in PaO2/FiO2 within 2-3 hours of administration of surfactant was seen. The patient is well at follow-up 1 year post-transplant.
Conclusion: There is a potential role for a combined therapy with inhaled nitric oxide and surfactant replacement in reperfusion injury after lung transplantation.
Figures
Comment in
-
What is the role of surfactant and inhaled nitric oxide in lung transplantation?Crit Care. 2002 Jun;6(3):186-7. doi: 10.1186/cc1484. Epub 2002 May 9. Crit Care. 2002. PMID: 12133173 Free PMC article.
Similar articles
-
What is the role of surfactant and inhaled nitric oxide in lung transplantation?Crit Care. 2002 Jun;6(3):186-7. doi: 10.1186/cc1484. Epub 2002 May 9. Crit Care. 2002. PMID: 12133173 Free PMC article.
-
Inhaled nitric oxide (NO) for the treatment of early allograft failure after lung transplantation. Munich Lung Transplant Group.Intensive Care Med. 1998 Nov;24(11):1173-80. doi: 10.1007/s001340050741. Intensive Care Med. 1998. PMID: 9876980 Clinical Trial.
-
Therapy for lung failure using nitric oxide inhalation and surfactant replacement.Ann Thorac Surg. 1996 May;61(5):1543-5. doi: 10.1016/0003-4975(95)01164-1. Ann Thorac Surg. 1996. PMID: 8633984
-
The effects of inhaled nitric oxide after lung transplantation.Minerva Anestesiol. 2010 May;76(5):353-61. Minerva Anestesiol. 2010. PMID: 20395898 Review.
-
Inhaled Pulmonary Vasodilators and Thoracic Organ Transplantation: Does Evidence Support Its Use and Cost Benefit?Semin Cardiothorac Vasc Anesth. 2020 Mar;24(1):67-73. doi: 10.1177/1089253219870636. Epub 2019 Aug 27. Semin Cardiothorac Vasc Anesth. 2020. PMID: 31451092 Review.
Cited by
-
Fungal infections in lung transplantation.J Thorac Dis. 2021 Nov;13(11):6695-6707. doi: 10.21037/jtd-2021-26. J Thorac Dis. 2021. PMID: 34992845 Free PMC article. Review.
-
Isavuconazole Is as Effective as and Better Tolerated Than Voriconazole for Antifungal Prophylaxis in Lung Transplant Recipients.Clin Infect Dis. 2021 Aug 2;73(3):416-426. doi: 10.1093/cid/ciaa652. Clin Infect Dis. 2021. PMID: 32463873 Free PMC article.
-
What is the role of surfactant and inhaled nitric oxide in lung transplantation?Crit Care. 2002 Jun;6(3):186-7. doi: 10.1186/cc1484. Epub 2002 May 9. Crit Care. 2002. PMID: 12133173 Free PMC article.
References
-
- Yamagishi H, Yamashita C, Okada M. Preventive influence of inhaled nitric oxide on lung ischemia-reperfusion injury. Jpn J Surg. 1999;29:897–901. - PubMed
-
- Hohlfeld JM, Tiryaki E, Hamm H, Hoymann HG, Krug N, Haverich A, Fabel H. Pulmonary surfactant activity is impaired in lung transplant recipients. Am J Respir Crit Care Med. 1998;158:706–712. - PubMed
-
- Richman PS, Spragg RG, Robertson B, Merritt TA, Curstedt T. The adult respiratory distress syndrome: first trials with surfactant replacement. Eur Respir J. 1989;2:109–111. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical